{
    "Case ID": "004766",
    "Crime_Name": [
        "Regulatory Offense (Drug Approval)"
    ],
    "Crime_Type": [
        "Violations of Immigration Regulations"
    ],
    "Violation_Type": [],
    "Legal_Issue": [
        "Whether Health Canada's refusal to grant Wellesley Therapeutics permission to market disulfiram in Canada was legally justified under the Food and Drugs Act and Regulations"
    ],
    "Governing_Law": [
        "Food and Drugs Act"
    ],
    "Application_Facts": [
        "Wellesley argued that disulfiram’s 50-year history in Canada established its safety and efficacy. Health Canada rejected this, citing insufficient evidence and requiring clinical trials."
    ],
    "Decision_Outcome": [
        "The court dismissed the DIN application (T-706-10) but allowed the NDS application (T-1537-07)"
    ],
    "Remedy_Requested": [
        "Judicial review of Health Canada’s decisions"
    ],
    "Court_Ruling": [
        "Health Canada must reconsider Wellesley’s NDS application considering all submissions and literature provided"
    ],
    "Claimant_Status": [
        "Wellesley Therapeutics"
    ],
    "Defendant_Behavior": [
        "Health Canada refused marketing permission and required clinical trial data despite long-standing use of disulfiram"
    ],
    "Grounds_for_Claim": [
        "Alleged unreasonable decision-making by Health Canada without proper analysis"
    ],
    "Legal_Standard": [
        "Reasonableness standard in administrative law"
    ],
    "Assessment_Factor": [
        "Sufficiency of evidence to establish safety and efficacy based on historical use"
    ],
    "Applicable_Legislation": [
        "Food and Drugs Act",
        "Food and Drugs Regulations"
    ],
    "Procedural_Issue": [
        "Judicial review applications filed to challenge regulatory decisions"
    ],
    "Review_Standard": [
        "Reasonableness"
    ],
    "Credibility_Assessment": [],
    "Evidence_Used": [
        "Affidavits, scientific literature, internal Health Canada documents"
    ],
    "Legal_Provision_Cited": [
        "Definition of 'new drug' under the Food and Drugs Act"
    ],
    "Application_Basis": [
        "Submission of a Notice of Compliance (NOC) with clinical trial data for a new drug"
    ],
    "Evidence_Assessed": [
        "Historical use of disulfiram, clinical data, regulatory precedents"
    ],
    "Relief_Sought": [
        "Reconsideration of NDS application and approval to market disulfiram"
    ],
    "Governing_Rule": [
        "A drug is 'new' if not sold in Canada in sufficient quantity and duration to establish safety and efficacy; requires NOC after clinical data submission"
    ],
    "Evidentiary_Deficiency": [
        "Health Canada cited lack of sufficient evidence despite long market history"
    ],
    "Outcome": [
        "DIN application dismissed; NDS application remitted for reconsideration"
    ],
    "Decisional_Body": [
        "Federal Court"
    ],
    "Harm_Assessment": [],
    "Cause_Description": [
        "Wellesley sought approval to reintroduce disulfiram into the Canadian market after its previous withdrawal, leading to disputes over regulatory requirements"
    ],
    "Evidence_Handling": [
        "Court found Health Canada failed to conduct substantive review of submitted literature and evidence"
    ],
    "Legal_Provision_Violated": [],
    "Evidence_Issues": [
        "Failure by Health Canada to properly analyze existing data and reliance on approvals of other drugs without justification"
    ],
    "Residency_Compliance": [],
    "Misrepresentation_Element": [],
    "Legal_Provision": [
        "Food and Drugs Act, sections related to new drug definition and NOC requirements"
    ],
    "Jurisdictional_Issue": [],
    "Evidence_Assessment": [
        "Court assessed whether Health Canada reasonably evaluated the evidence"
    ],
    "Decision_Rationale": [
        "Health Canada's rejection was unreasonable due to lack of substantive review and inadequate reasoning"
    ],
    "Country_of_Origin": [
        "Canada"
    ],
    "Decision_Making_Body": [
        "Health Canada"
    ],
    "Evidentiary_Issues": [
        "Insufficient consideration of long-term use data and external scientific literature"
    ],
    "Legal_Standard_Applied": [
        "Reasonableness"
    ]
}